EA201690072A1 - Состав, содержащий гиполипидемическое средство - Google Patents

Состав, содержащий гиполипидемическое средство

Info

Publication number
EA201690072A1
EA201690072A1 EA201690072A EA201690072A EA201690072A1 EA 201690072 A1 EA201690072 A1 EA 201690072A1 EA 201690072 A EA201690072 A EA 201690072A EA 201690072 A EA201690072 A EA 201690072A EA 201690072 A1 EA201690072 A1 EA 201690072A1
Authority
EA
Eurasian Patent Office
Prior art keywords
formula
hypolipidemic
composition containing
present
compounds
Prior art date
Application number
EA201690072A
Other languages
English (en)
Inventor
Джитендре Д. Пател
Пракаш Давадра
Снехал Пател
Шафик Шеикх
Original Assignee
Кадила Хелзкэр Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кадила Хелзкэр Лимитед filed Critical Кадила Хелзкэр Лимитед
Publication of EA201690072A1 publication Critical patent/EA201690072A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Abstract

Настоящее изобретение относится к стабильной фармацевтической композиции подходящего гиполипидемического средства. Предпочтительно настоящее изобретение раскрывает новые составы соединения формулы (I) или фармацевтически приемлемых солей соединений формулы (I). Более конкретно, настоящее изобретение относится к стабильной фармацевтической композиции соединений формулы (I), содержащей соединения формулы (I), или их фармацевтически приемлемые соли, где рН состава поддерживают выше 7.
EA201690072A 2013-07-25 2014-07-24 Состав, содержащий гиполипидемическое средство EA201690072A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2470MU2013 IN2013MU02470A (ru) 2013-07-25 2013-07-25
PCT/IN2014/000489 WO2015011730A1 (en) 2013-07-25 2014-07-24 Formulation comprising a hypolipidemic agent

Publications (1)

Publication Number Publication Date
EA201690072A1 true EA201690072A1 (ru) 2016-06-30

Family

ID=51787141

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201690072A EA201690072A1 (ru) 2013-07-25 2014-07-24 Состав, содержащий гиполипидемическое средство

Country Status (21)

Country Link
US (2) US9610277B2 (ru)
EP (1) EP3024446A1 (ru)
JP (1) JP2016523895A (ru)
KR (1) KR101786843B1 (ru)
CN (1) CN105407873A (ru)
AP (1) AP2015008876A0 (ru)
AR (1) AR097067A1 (ru)
AU (1) AU2014294548B2 (ru)
BR (1) BR112015031878A2 (ru)
CA (1) CA2917923A1 (ru)
EA (1) EA201690072A1 (ru)
HK (1) HK1219222A1 (ru)
IN (1) IN2013MU02470A (ru)
MA (1) MA38865A1 (ru)
MX (1) MX2015016971A (ru)
NZ (1) NZ714558A (ru)
PH (1) PH12015502802A1 (ru)
SG (1) SG11201509798PA (ru)
TW (1) TW201545773A (ru)
WO (1) WO2015011730A1 (ru)
ZA (1) ZA201508682B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101427486B (zh) 2006-05-23 2013-06-19 英特尔公司 具有定向天线和一个或多个毫米波反射器的毫米波通信系统
SI2670486T1 (sl) 2011-01-31 2016-09-30 Cadila Healthcare Limited Zydus Tower Satellite Cross Roads Zdravljenje lipodistrofije
AU2013387996B2 (en) 2013-04-22 2015-12-10 Cadila Healthcare Limited A novel composition for nonalcoholic fatty liver disease (NAFLD)
WO2014195967A2 (en) 2013-05-30 2014-12-11 Cadila Healthcare Limited A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities
TW201636015A (zh) 2013-07-05 2016-10-16 卡地拉保健有限公司 協同性組成物
IN2013MU02470A (ru) 2013-07-25 2015-06-26 Cadila Healthcare Ltd
IN2013MU02905A (ru) 2013-09-06 2015-07-03 Cadila Healthcare Ltd
US10385017B2 (en) 2015-10-14 2019-08-20 Cadila Healthcare Limited Pyrrole compound, compositions and process for preparation thereof
KR101913830B1 (ko) * 2016-12-05 2018-10-31 주식회사 코쿤디자인 기능성 led 어셈블리를 이용한 디스플레이 장치
BR112019011740A2 (pt) 2016-12-09 2019-10-29 Cadila Healthcare Ltd composição farmacêutica e método para o tratamento de colangite biliar primária
EP3923932A4 (en) * 2019-02-13 2022-11-16 Cadila Healthcare Limited TREATMENT OF POLYCYSTIC OVARY SYNDROME (PCOS)
WO2020183379A1 (en) * 2019-03-11 2020-09-17 Cadila Healthcare Limited Novel salts, crystalline forms and premix of hypolipidemic agent

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444784A (en) 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
DK149080C (da) 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
US5354772A (en) 1982-11-22 1994-10-11 Sandoz Pharm. Corp. Indole analogs of mevalonolactone and derivatives thereof
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
PL174610B1 (pl) 1992-07-03 1998-08-31 Smithkline Beecham Plc Nowe związki heterocykliczne
GB9225386D0 (en) 1992-12-04 1993-01-27 Smithkline Beecham Plc Novel compounds
US5387613A (en) 1993-07-23 1995-02-07 Ribogene, Inc. Treatment of tachyarrhythmias of supraventricular origin
GB9326171D0 (en) 1993-12-22 1994-02-23 Smithkline Beecham Plc Novel compounds
BR9508468A (pt) 1994-07-29 1997-11-25 Smithkline Beecham Plc Composto processo para a preparação do mesmo composição farmacéutica processos para o tratamento e/ou profilaxia de hiperglicemia em um mamifero humano ou não humano e para o tratamento de hiperlípidemia hipertensão doença cardiovascular alguns distúrbios de alimentação o tratamento e/ou profilaxia de doença renal a prevenção revers o estabilização ou retardo da progressão de microalbuminuria em um mamifero humano ou não humano uso do composto e composto intermediário
DE69615016T2 (de) 1995-04-28 2002-05-02 Daiichi Seiyaku Co Pentacyclische verbindungen
GB9600464D0 (en) 1996-01-09 1996-03-13 Smithkline Beecham Plc Novel method
GB9606805D0 (en) 1996-03-30 1996-06-05 Glaxo Wellcome Inc Medicaments
EP1124807A1 (en) 1997-10-27 2001-08-22 Dr. Reddy's Research Foundation Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
WO1999019313A1 (en) 1997-10-27 1999-04-22 Dr. Reddy's Research Foundation Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
ATE286032T1 (de) 1998-04-23 2005-01-15 Reddys Lab Ltd Dr Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
CN100357281C (zh) 1998-05-27 2007-12-26 雷迪实验室有限公司 双环化合物、其制备方法和包含它们的药物组合物
AU6325599A (en) 1998-10-21 2000-05-08 Dr. Reddy's Research Foundation New compounds, their preparation and use
WO2000023417A1 (en) 1998-10-21 2000-04-27 Novo Nordisk A/S New compounds, their preparation and use
AU6325799A (en) 1998-10-21 2000-05-08 Dr. Reddy's Research Foundation New compounds, their preparation and use
CO5150173A1 (es) 1998-12-10 2002-04-29 Novartis Ag Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
EP1250323B1 (en) 2000-01-19 2014-01-01 Cadila Healthcare Limited Compounds having hypolipidemic and hypocholesterolemic activities, process for their preparation and pharmaceutical compositions containing them
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
WO2002024625A2 (en) 2000-09-22 2002-03-28 Dr. Reddy's Research Foundation Process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives
UA74912C2 (en) 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
US6987123B2 (en) 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
JP4745616B2 (ja) * 2003-02-26 2011-08-10 武田薬品工業株式会社 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾール誘導体の安定化方法
WO2005031335A1 (ja) 2003-09-26 2005-04-07 Mitsubishi Rayon Co., Ltd. 電気泳動装置および電気泳動法並びにそれを用いた生体関連物質の検出方法
CN102134229B (zh) 2004-03-15 2020-08-04 武田药品工业株式会社 二肽基肽酶抑制剂
WO2007097386A1 (ja) * 2006-02-22 2007-08-30 Eisai R & D Management Co., Ltd. 安定化医薬組成物
EP2018157A2 (en) 2006-04-26 2009-01-28 Astron Research Limited Controlled release formulation comprising anti-epileptic drugs
JP5424571B2 (ja) * 2007-04-12 2014-02-26 協和発酵キリン株式会社 トピラマート含有固形製剤
NZ600439A (en) 2009-11-26 2014-06-27 Genfit Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
CN103347506A (zh) * 2010-10-12 2013-10-09 约翰.霍普金斯大学 包含美金刚的镇咳组合物
SI2670486T1 (sl) * 2011-01-31 2016-09-30 Cadila Healthcare Limited Zydus Tower Satellite Cross Roads Zdravljenje lipodistrofije
AU2013387996B2 (en) 2013-04-22 2015-12-10 Cadila Healthcare Limited A novel composition for nonalcoholic fatty liver disease (NAFLD)
WO2014195967A2 (en) 2013-05-30 2014-12-11 Cadila Healthcare Limited A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities
TW201636015A (zh) 2013-07-05 2016-10-16 卡地拉保健有限公司 協同性組成物
IN2013MU02470A (ru) 2013-07-25 2015-06-26 Cadila Healthcare Ltd
IN2013MU02828A (ru) 2013-08-29 2015-07-03 Cadila Healthcare Ltd
IN2013MU02905A (ru) 2013-09-06 2015-07-03 Cadila Healthcare Ltd

Also Published As

Publication number Publication date
WO2015011730A1 (en) 2015-01-29
BR112015031878A2 (pt) 2017-07-25
CA2917923A1 (en) 2015-01-29
AU2014294548A1 (en) 2015-12-17
EP3024446A1 (en) 2016-06-01
AP2015008876A0 (en) 2015-11-30
KR101786843B1 (ko) 2017-10-18
CN105407873A (zh) 2016-03-16
IN2013MU02470A (ru) 2015-06-26
TW201545773A (zh) 2015-12-16
HK1219222A1 (zh) 2017-03-31
JP2016523895A (ja) 2016-08-12
US20170266158A1 (en) 2017-09-21
PH12015502802A1 (en) 2016-03-14
AR097067A1 (es) 2016-02-17
SG11201509798PA (en) 2016-02-26
US9610277B2 (en) 2017-04-04
US20160136131A1 (en) 2016-05-19
US10098868B2 (en) 2018-10-16
KR20160013150A (ko) 2016-02-03
MA38865A1 (fr) 2017-12-29
MX2015016971A (es) 2016-04-25
ZA201508682B (en) 2017-03-29
AU2014294548B2 (en) 2017-08-10
NZ714558A (en) 2017-02-24

Similar Documents

Publication Publication Date Title
EA201690072A1 (ru) Состав, содержащий гиполипидемическое средство
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
BR112015021983A8 (pt) compostos heterocíclicos, composições e usos dos mesmos
EA201690598A1 (ru) Аминогетероарил бензамиды в качестве ингибиторов киназы
NZ716840A (en) Combination formulation of two antiviral compounds
PE20151781A1 (es) Piridonamidas como moduladores de canales de sodio
EA201700230A1 (ru) Определенные аминопиридины, композиции на их основе и способы их применения
EA201001683A1 (ru) Производные фенил- или пиридинилзамещенных индазолов
EA201270216A1 (ru) Фармацевтический состав
RS54730B1 (sr) Inhibitori beta sekretaze
EA201691119A1 (ru) Производные мочевины или их фармакологически приемлемые соли
EA201690247A1 (ru) Аминометилбиарильные производные-ингибиторы фактора d комплемента и их применения
RS54526B1 (en) USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
PH12015501752A1 (en) Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors
EA201792597A2 (ru) Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения
EA201592268A1 (ru) Дигидропиридиноновые ингибиторы mgat2
MX364400B (es) Compuestos de tetraciclina.
EA201690621A1 (ru) Полиэтиленгликольсодержащие композиции
PH12014501181A1 (en) N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
PH12016500577B1 (en) Piperazine derivatives and the use thereof as medicament
EP4282973A3 (en) Processes for the preparation of pyrimidinylcyclopentane compounds
CY1120482T1 (el) Μεθοδος συνθεσης 3,4-διμεθοξυδικυκλο[4.2.0]οκτα-1,3,5-τριενο-7-καρβονιτριλιου και εφαρμογη στη συνθεση της ιβαμπραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξy
EA201690908A1 (ru) Пиразолопиримидиновые соединения